Under the category of the OTC/Nutraceutical products are listed the products which are sold without prescription. Members of Farmavita.net are invited to publish their out-license offers in this Category.

Azithromycin dihydrate

Popular

Description

There is on-going development of generic EU CTD Dossier of Azithromycin dihydrate, tablets, 250/500 mg.

DCP slots will be available in November 2009.

Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.

Azithromycin is used to treat or prevent certain bacterial infections, most often those causing middle ear infections, tonsillitis, throat infections, laryngitis, bronchitis, pneumonia, Typhoid, yeast infections, and sinusitis. In recent years it has primarily been used to prevent bacterial infections in infants and those with weaker immune systems. It is also effective against certain urinary tract infections, such as non-gonococcal urethritis and cervicitis. Recent studies have also indicated it to be effective against late-onset asthma, but these findings are controversial and not widely accepted.

More details at: http://www.rxlist.com/zithromax-drug.htm.

More details

Name Description
Pharma licensing Out-licensing (offer)

Ad details

Ad ID : 593

Advertiser details

Contact Advertiser

Add comment

 
 

Contact form

Sorry, you need to register or login first.

What's wrong with this ad?

Sorry, you need to register or login first.

Add to favourites

Sorry, you need to register or login first.

Advert search

Recent adverts

Start-up pharmaceutical company from South...
169 Views
Member of Farmavita.net is looking to...
286 Views
I want to give process knowhow and NON GMO...
n/a
806 Views
OUT-LICENSING HYBRID DOSSIER OF ALIMEMAZINE...
1061 Views
 Company portfolio: Manufacturing over 100...
1413 Views
Objective: To enter into EU domain procuring...
1192 Views
Objective: To enter into EU domain grabbing a...
943 Views